Unusual skin changes in 4yearold SCID patient - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

Unusual skin changes in 4yearold SCID patient

Description:

Extensive candidiasis in the mouth and diaper area may persist and involve the rest of the skin ... 4-year-old girl: young, non-consanguinous parents. healthy, ... – PowerPoint PPT presentation

Number of Views:145
Avg rating:3.0/5.0
Slides: 27
Provided by: p0054551
Category:

less

Transcript and Presenter's Notes

Title: Unusual skin changes in 4yearold SCID patient


1
Unusual skin changes in 4-year-old SCID patient
  • Edyta Heropolitanska-Pliszka
  • Magdalena Kurenko-Deptuch
  • Immunology Department
  • Childrens Memorial Health Institute
  • Warsaw Poland




  • PRAGUE 2007

2
Registry of PIDs in CMHI1980 2006 n
102129 SCID / 6 OS
3
Cutaneous disorders in SCID patients
  • Recurrent skin abscesses
  • Extensive candidiasis in the mouth and diaper
    area may persist and involve the rest of the skin
  • Intractable eczemalike dermatitis
  • Severe seborrheic dermatitis over the scalp,
    ears, and nasolabial folds
  • Impetigo and severe skin infections with deep
    ulcers in the perineum, tongue, and buccal mucosa
  • Sparse hair and absence of the eyebrows and
    eyelashes
  • Manifestations of graft-versus-host disease
    (GVHD) that ensue a few days to weeks after
    transfusion include
  • in the acute setting a maculopapular or
    morbilliform rash with progress to erythroderma
    and exfoliative dermatitis
  • in chronic GVHD lichenoid or sclerodermoid
    lesions

4
Exfoliative erythrodermy in Omenn Syndrome
on CsA treatment
5
Impetigo and severe skin infection
6
Skin changes in BCG-itis
7
Extensive fungal infection
8
Extensive candidiasis
9
Materno-fetal engraftment
10
Acute GVHD after non-irradiated, non-filtrated
blood transfusion
11
Chronic GVHD 150 days after HSCT
12
4-year-old girl
  • young, non-consanguinous parents
  • healthy, elder brother,
  • II-nd pregnancy, II-nd delivery after caesarean
    operation, b.w. 3030g
  • vaccinated with BCG and hepatitis B after birth
  • breast-fed for 16 months

13
  • 2 m.o. - dermatitis atopica
  • 18 m.o. - pneumonitis, diarrhea, maculo-papular
    skin changes on extremities, lymphopenia (WBC
    9100 L-9)
  • 20 m.o. - erosive stomatitis, failure to thrive,
    papulo-vescicular eruptions on extremities,
    lymphopenia (WBC 9300 L-14)
  • DIAGNOSIS benign histiocytosis
  • 21 m.o. - bronchitis obturativa, extensive oral
    thrush, failure to thrive, papulo-erthrodermatous
    eruptions on extremities, buttocks and face
  • DIAGNOSIS lymphoma benignum cutis

14
  • 32 m.o. - bronchitis obturativa, uticaria
    pigmentosa , failure to thrive, normal
    immunoglobuline concentration (IgG-550 mg/dl)
  • DIAGNOSIS mastocytosis
  • 36 m.o. - bronchitis obturativa, failure to
    thrive, leukopenia with agranulocytosis (WBC
    2200 N-11)
  • DIAGNOSIS systemic disease
  • 40 m.o. admitted to Immunology Department CMHI
  • failure to thrive, papulo-macular skin
    changes with small scales and scarring on
    extremities, buttoks, face, obturative
    bronchopneumonia
  • DIAGNOSIS primary immunodeficiency disorder

15
Basic blood tests
  • GOT 42 U/l
  • GPT 35 U/l
  • CRP lt0,2 mg/dl
  • LDH 265 U/l
  • WBC - 5,4 K/ul
  • N-77
  • L-17
  • E-3
  • B-3
  • RBC - 3,66 M/ul
  • Hgb - 12,2 g/dl
  • Plt - 260 K/ul

16
Microbiological investigation
  • Pneumocystis carini PCR in blood and BAL
    negative
  • Mycoplasma sp., Chlamydia sp., Legionella sp.
    negative
  • Mycobacterium tuberculosis PCR in BAL negative
  • HIV-1 PCR negative
  • HHV 6 PCR negative
  • HSV DNA - negative
  • HCMV PCR DNA in leukocytes and urine both
    positive
  • Aspergillus sp. index ELISA (0,660) and PCR ()

17
Humoral immunity
  • IgG 1020 2013 mg/dl
  • IgA 21 mg/dl
  • IgM 147 mg/dl
  • IgE 52 KU/L
  • IgG1 990 mg/dl
  • IgG2 lt11 mg/dl
  • IgG3 16 mg/dl
  • IgG4 lt0,4 mg/dl
  • Monoclonal gammapathy IgG kappa
  • Anty-HBs 0,0 after triple vaccination,
    anty-diphteria and anty-tetanus 0,0 after
    four-time-vaccination

18
Cellular immunity
  • CD45/SSC low 1517 kom/ul
  • CD3/CD45 - 40,6 615 kom/ul
  • CD3CD8/CD45 - 15,5 235 kom/ul
  • CD3CD4/CD45 - 18,2 275 kom/ul
  • CD1656/CD45 - 43,9 665 kom/ul
  • CD19/CD45 - 10,5 160 kom/ul
  • Control 117 /- 28
  • PHA 675 /- 84
  • CD3 2654 /- 370
  • Chimerism VNTR no maternal engraftment

19
Imaging studies
  • USG - thymus present, no hepatosplenomegaly,
    lymphoadenopathy in nitch of liver and spleen
  • Chest radiographs interstitial pneumonitis in
    both lungs
  • CT scans enlarged lymph nodes in mediastinum
    interstitial infiltration with fibrous changes in
    both apexes
  • HRCT permanent fibrous changes in both apexes
    enlarged lymph nodes in mediastinum

20
Histologic findings
  • BMA no signs of malignancy
  • Skin biopsy
  • - microscopy predominantly histiocytic
    infiltrates with lymphocytes present in the
    dermis and subcutaneous tissue with tendency to
    form granulomatous forms In T cell population
    predominance of T cytotoxic, less amount of T
    helper, the least of B cells
  • - immunohistochemical reactions CD1a
    negative, CD68 positive (abundant reaction), Ki67
    and CD20 positive in small part of lymphocytes,
    CD3 positive in most lymphocytes.

DIAGNOSIS histiocytoma eruptivum generalisatum
21
(No Transcript)
22
DIAGNOSIS
  • OMENN SYNDROME
  • T- B- NK SCID

23
  • Frozen skin biopsy PCR analysis of the T-cell
    receptor (TCR) genes
  • analysis of TCRB / TCRG repertoire showed
    reproducible oligoclonal patterns with
    predominant clones shared between the two
    samples. It might reflect (antigen-driven?)
    selective outgrowth of T cells, which might be
    compatibile with an inflammatory reaction in the
    context of the presumed SCID syndrome


  • Thanks to Dr T. Langerak

  • Erasmus
    University

24
Genetical diagnosis
  • OMENN SYNDROME
  • RAG-1/RAG-2 excluded
  • Artemis excluded on the basis of low
    radiosensitivity
  • IL7RA not tested
  • Others ???
  • Thanks to Prof. J.J. van Dongen
  • Dr M. van der Burg

25
Treatment
  • antibacterial (PCP prophylaxis broad- spectrum
    antibiotics)
  • antiviral agents (Gancyclovir)
  • antifungal therapy (Amphomoronal, Worikonazol)
  • IVIG every 7-10 days
  • immunosupressive treatment (CsA,
  • Encorton (1mg/kg.b.))

26
HSCT
  • March 2007 MUD PBPC
  • Conditioning regimen (BuCyATG)
  • Early outcome
  • 10 day Engraftment Syndrome
  • 15 day - good haematological reconstitution
  • 20 day - GVHD II stage in skin (CsA,
    steroids)
  • 27 day reactivation of HCMV infection
    (Gancyclovir, Foscarnet)
  • 39 day - complete chimerism
  • 75 day good condition, no infection, still
    skin changes, chimerism pending
Write a Comment
User Comments (0)
About PowerShow.com